Pre-exposure Prophylaxis Uptake and Discontinuation Among Young Black Men Who Have Sex With Men in Atlanta, Georgia: A Prospective Cohort Study
- 10 September 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 71 (3) , 574-582
Abstract
Background: Human immunodeficiency virus (HIV) preexposure prophylaxis (PrEP) has great potential to reduce HIV incidence among young black men who have sex with men (YBMSM); however, initiation and persistence for this group remain low. We sought to understand the patterns and predictors of PrEP uptake and discontinuation among YBMSM in Atlanta, Georgia.Methods: PrEP was offered to all participants in a prospective cohort of YBMSM aged 18–29 years not living with HIV. Time to PrEP uptake, first discontinuation, and final discontinuation were assessed using the Kaplan-Meier method. Cox proportional hazard models were used to identify predictors of uptake and discontinuation.Results: After 440 person-years of follow-up, 44% of YBMSM initiated PrEP through the study after a median of 122 days. Of PrEP initiators, 69% had a first discontinuation and 40% had a final discontinuation during the study period. The median time to first PrEP discontinuation was 159 days. Factors associated with PrEP uptake included higher self-efficacy, sexually transmitted infection (STI), and condomless anal intercourse. Factors associated with discontinuation included younger age, cannabis use, STI, and fewer sex partners. HIV incidence was 5.23/100 person-years (95% confidence interval [CI], 3.40–7.23), with a lower rate among those who started PrEP (incidence rate ratio, 0.39; 95% CI, .16–.92).Conclusions: Persistent PrEP coverage in this cohort of YBMSM was suboptimal, and discontinuations were common despite additional support services available through the study. Interventions to support PrEP uptake and persistence, especially for younger and substance-using YBMSM, are necessary to achieve full PrEP effectiveness.Clinical Trials Registration: NCT02503618.Keywords
Funding Information
- National Institutes of Health (R01DA038196, K23AI108335, UL1TR002378, TL1TR002382, P30 AI050409)
- Gilead Sciences (IN-US-276-4369)
This publication has 37 references indexed in Scilit:
- Retention in care outcomes for HIV pre‐exposure prophylaxis implementation programmes among men who have sex with men in three US citiesJournal of the International AIDS Society, 2016
- Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trialThe Lancet, 2016
- Marijuana Use as a Sex-Drug is Associated with HIV Risk Among Black MSM and Their NetworkAIDS and Behavior, 2015
- Heterogeneity of HIV Prevalence Among the Sexual Networks of Black and White Men Who Have Sex With Men in AtlantaSexually Transmitted Diseases, 2015
- Applying a PrEP Continuum of Care for Men Who Have Sex With Men in Atlanta, GeorgiaClinical Infectious Diseases, 2015
- Dose Response for Starting and Stopping HIV Preexposure Prophylaxis for Men Who Have Sex With MenClinical Infectious Diseases, 2014
- Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort studyThe Lancet Infectious Diseases, 2014
- The PHQ-8 as a measure of current depression in the general populationJournal of Affective Disorders, 2009
- Anxiety Disorders in Primary Care: Prevalence, Impairment, Comorbidity, and DetectionAnnals of Internal Medicine, 2007
- Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption‐IIAddiction, 1993